Tianjin Zhongxin Pharma's 3Q2021 earnings rise 30% to $41.8mil on higher sales

Tianjin Zhongxin Pharmaceutical Group announced earnings of RMB198.9 million ($41.8 million) in 3Q2021, up 30% from the previous corresponding period.

In 9M2021, net attributable profit stood at RMB661.5 million, a 39% increase y-o-y, mainly due to an increase in sales.